Skip to content
News

SPOG Young Investigator Grant 2027: Applications Now Open

SPOG is launching the Young Investigator Grant 2027 and invites young researchers at SPOG member clinics to submit projects in paediatric oncology. Up to two projects will be funded with a total of CHF 75,000.

The grant is aimed at researchers under 40 years of age in a permanent position at one of the nine SPOG member clinics. The applicant bears sole scientific responsibility as Principal Investigator. SPOG’s independent international Scientific Advisory Board (SAB) evaluates the full applications; the SPOG Board of Directors decides on the allocation.

 

Supporting the next generation of researchers

Since the first award in 2021, the grant has already supported six young researchers in their scientific careers – always with a direct link to the care of children and young people with cancer.

2021
Dr. med. Christa König PhD, Continuous monitoring of vital signs with wearable devices in pediatric patients undergoing chemotherapy
Dr. med. Maria Otth PhD, Aftercare of Childhood Cancer Survivors in Switzerland – General Practitioner Model

2022
Dr. med. Rahel Kasteler PhD, Needs and quality of life in Ukrainian children with cancer in the context of the Ukrainian-Russian war
Dr. med. Christine Schneider PhD, Early pulmonary dysfunction in paediatric cancer patients

2025
Dr. med. Arianna Piffer, Advancing Deep Learning for Pediatric Low-Grade Glioma Segmentation
Dr. med. Uli Simon Herrmann PhD, In depth spatial characterization of the tumor microenvironment of Wilms tumor (MapWiTME)

 

Would you like to be part of this series? A Letter of Intent can be submitted by 1 June 2026. All information on requirements, deadlines, and submission can be found in the following PDF: Call for Applicants

 

Published 16.04.2026
Share article 
Catia Gehrig
Catia Gehrig

Catia Gehrig is Head Partner Relations at SPOG and is responsible for communications, fundraising and administration. She is a passionate communicator and networker for paediatric cancer research.

More articles from Catia Gehrig

More articles